Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis receives European Commission approval for self-administration of Xolair® across all indications

en-cphi.cnDecember 14, 2018

Tag: Novartis , Xolair , EC , severe allergic asthma , SAA

PharmaSources Customer Service